Xenon Pharmaceuticals (XENE) PT Lowered to $63 at Wedbush

March 16, 2026 6:44 AM

Wedbush analyst Laura Chico lowered the price target on Xenon Pharmaceuticals (NASDAQ: XENE) to $63.00 (from $64.00) while maintaining a ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found